Addex Therapeutics Ltd (SWX:ADXN)
Switzerland · Delayed Price · Currency is CHF 0.0420
+0.0014 (3.45%)
Jul 31, 2026, 5:30 PM CET
Addex Therapeutics Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -6.97 | -6.73 | 7.06 | -10.56 | -20.8 | -15.35 |
Depreciation & Amortization | 0.02 | 0.01 | 0.19 | 0.01 | 0.01 | 0.35 |
Loss (Gain) on Equity Investments | 4.39 | 4.01 | 2.18 | - | - | - |
Stock-Based Compensation | 0.07 | 0.07 | 0.18 | 0.28 | 0.68 | 1.34 |
Other Operating Activities | 0.01 | 0.03 | -0.18 | 0.29 | 0.2 | -0.28 |
Change in Accounts Receivable | 0 | -0 | 0.13 | 0.45 | -0.27 | -0.26 |
Change in Accounts Payable | 0.14 | 0.39 | -1.15 | -0.61 | -0.43 | 0.88 |
Change in Unearned Revenue | - | - | -0.04 | 0.32 | - | -0.82 |
Change in Other Net Operating Assets | 0.11 | 0.16 | -0.18 | 0.06 | 0.86 | -0.57 |
Operating Cash Flow | -2.34 | -2.17 | -5.37 | -7.99 | -16.44 | -14.71 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | -0 | -0.01 | -0 | -0.03 |
Investment in Securities | -0.29 | -0.29 | - | - | 0 | 0 |
Other Investing Activities | -0.39 | -0.39 | 4.65 | - | - | - |
Investing Cash Flow | -0.68 | -0.68 | 4.65 | -0.01 | 0 | -0.03 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -0.01 | -0.07 | -0.28 | -0.29 | -0.31 |
Net Debt Issued (Repaid) | -0.01 | -0.01 | -0.07 | -0.28 | -0.29 | -0.31 |
Issuance of Common Stock | 1.3 | 1.23 | 0.24 | 2.35 | 1.68 | 13.96 |
Repurchase of Common Stock | -0.04 | -0.04 | -0.03 | -0.05 | -0.31 | -0.39 |
Other Financing Activities | -0.11 | -0 | -0.04 | 3.24 | 2.02 | 3.14 |
Financing Cash Flow | 1.15 | 1.18 | 0.1 | 5.26 | 3.1 | 16.4 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.02 | -0.04 | 0.1 | -0.36 | -0.2 | 0.12 |
Net Cash Flow | -1.89 | -1.7 | -0.52 | -3.09 | -13.53 | 1.79 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.34 | -2.17 | -5.37 | -8 | -16.44 | -14.74 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -2135.47% | -1256.00% | -1310.80% | -494.64% | -1137.59% | -467.34% |
Free Cash Flow Per Share | -0.02 | -0.02 | -0.06 | -0.11 | -0.36 | -0.43 |
Levered Free Cash Flow | -1.52 | -1.27 | -3.36 | -0.99 | -6.19 | -8.2 |
Unlevered Free Cash Flow | -1.52 | -1.27 | -3.36 | -0.99 | -6.17 | -8.16 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0 | 0 | 0.01 | 0.02 | 0.05 | 0.06 |
Change in Working Capital | 0.25 | 0.55 | -1.23 | 0.21 | 0.16 | -0.76 |